Ossdsign AB (Publ) reported revenues for the period October - November 2023. For the period, company reported Preliminary total revenues amount to SEK 25.2 million, mainly attributable to a continued strong market performance of the orthobiologics franchise and some extraordinary orders from a large hospital system. According to preliminary and unaudited data, sales of OssDsign Catalyst amounted to SEK 18.8 million during the period of October - November 2023, whereas OssDsign Cranial recorded sales of SEK 6.4 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.64 SEK | -1.73% | -6.77% | +20.50% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.50% | 88.34M | |
+8.29% | 124B | |
-5.61% | 11.02B | |
+4.83% | 8.88B | |
+39.60% | 5.45B | |
-22.04% | 4.74B | |
+8.39% | 3.44B | |
-6.28% | 2.84B | |
-10.23% | 2.15B | |
-5.99% | 2.11B |
- Stock Market
- Equities
- OSSD Stock
- News OssDsign AB
- Ossdsign AB Reports Revenues for the Period October - November 2023